3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
19
Ovarian Neoplasms
7
Leiomyosarcoma
6
Liposarcoma
4
Liposarcoma, Myxoid
3
Sarcoma, Ewing
2
Osteosarcoma
2
Solitary Fibrous Tumors
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyosarcoma Uterus
1
Ichthyosis, X-Linked
1
Histiocytoma, Malignant Fibrous
1
Hemangioendothelioma
1
Fanconi Anemia, Complementation Group D1
1
Chondrosarcoma
1
Carcinosarcoma
1
Cancers With DNA Repair-Deficiency
1
Bone Neoplasms
1
Interventions
pazopanib
2
Ifosfamide
2
Doxorubicin
2
selinexor
1
Trabectedin
1
Sunitinib
1
Proton Therapy
1
Nivolumab
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Epirubicin
1
Dasatinib
1
Dacarbazine
1
Cisplatin
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Solitary Fibrous Tumors
×
Trabectedin
×
Clear all
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled